Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Head/Neck
Phase II
Adults
Chemotherapy - cytotoxic, Mol. targeted/Immunotherapy/Biologics, Radiotherapy
Cisplatin, MK-3475, Pembrolizumab (MK-3475)
Lockney, Natalie
National
Vanderbilt University
05-21-2020
Treatment
VICCHN1966
NCT03383094

Eligibility

Not Available
Not Available
Not Available

To learn more about any of our clinical
trials, call 615-936-8422.